Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

  • There is currently no data for MXCT

MaxCyte News

MaxCyte to consolidate two of its lines of shares
13 May 2021

MaxCyte to consolidate two of its lines of shares

(Sharecast News) - Cell engineering company MaxCyte announced the consolidation of two of its lines of common stock into a single unrestricted line of...

TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss
20 Apr 2021

TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss

TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss

MaxCyte reports good performance despite Covid challenges
20 Apr 2021

MaxCyte reports good performance despite Covid challenges

(Sharecast News) - Cell engineering technology company MaxCyte reported a 21% year-on-year improvement in revenues in its final results on Tuesday, to...

MaxCyte raises £40m from new and existing investors
4 Feb 2021

MaxCyte raises £40m from new and existing investors

(Sharecast News) - Cell engineering and life sciences company MaxCyte has announced a subscription to raise £40m, in a bid to strengthen its bala...

IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing
3 Feb 2021

IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing

IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing

LONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%
20 Jan 2021

LONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%

LONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020
11 Jan 2021

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

Maxcyte Core Life Sciences Business Results To Beat Expectations
23 Dec 2020

Maxcyte Core Life Sciences Business Results To Beat Expectations

Maxcyte Core Life Sciences Business Results To Beat Expectations